retatrutide progress 12 Weeks on 11 week progress update :)

What labs should women with PMOS ask about before considering GLP-1s

At the metabolic level, dysbiosis can disrupt bile acid metabolism by increasing hydrophobic toxic bile acids while suppressing intestinal FXR signaling and fibroblast growth factor 19 (FGF19) expression, thereby relieving the negative feedback inhibition of hepatic cholesterol 7-hydroxylase (CYP7A1) and promoting bile acid pool expansion and hepatocellular lipotoxicity [285, 286]

Vaughn AR, Branum A, Sivamani RK

Efectos secundarios menos comunes pero ms graves incluyen pancreatitis aguda, que se manifiesta con dolor abdominal intenso y persistente que puede irradiarse a la espalda

Medication sourcing and disclosure: Compounded GLP-1 medications available through the platform are not FDA-approved finished drug products

This suggests Ro, one of the major platforms providing compounded versions of weight loss drugs, is preparing for a post-shortages future